Meeder Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9M Buy
19,473
+76
+0.4% +$77K 0.75% 24
2025
Q4
$20.8M Buy
19,397
+2,023
+12% +$1.93M 0.89% 24
2025
Q3
$13.3M Buy
17,374
+147
+0.9% +$109K 0.62% 29
2025
Q2
$13.4M Buy
17,227
+279
+2% +$217K 0.7% 27
2025
Q1
$14M Buy
16,948
+646
+4% +$538K 0.84% 23
2024
Q4
$12.6M Buy
16,302
+541
+3% +$448K 0.79% 24
2024
Q3
$14M Buy
15,761
+438
+3% +$394K 0.9% 22
2024
Q2
$13.9M Buy
15,323
+4,471
+41% +$3.58M 0.98% 19
2024
Q1
$8.44M Buy
10,852
+300
+3% +$214K 0.86% 21
2023
Q4
$6.15M Sell
10,552
-72
-0.7% -$42K 0.7% 24
2023
Q3
$5.71M Sell
10,624
-603
-5% -$311K 0.72% 25
2023
Q2
$5.27M Buy
11,227
+575
+5% +$241K 0.57% 29
2023
Q1
$3.66M Sell
10,652
-549
-5% -$185K 0.42% 39
2022
Q4
$4.1M Buy
+11,201
New +$3.97M 0.52% 32

Other funds holding LLY

Meeder Advisory Services's LLY Position: Q1 2026 in Review

Meeder Advisory Services increased its Eli Lilly (LLY) stake by 0.39% in Q1 2026, buying an estimated $77K and bringing the position to 19,473 shares worth $17.9M. The position accounts for 0.75% of the portfolio, ranked #24.

Meeder Advisory Services first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $20.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Meeder Advisory Services held 19,473 shares of Eli Lilly worth $17.9M as of Q1 2026.
  • Meeder Advisory Services bought 76 Eli Lilly shares in Q1 2026, an estimated $77K.
  • Eli Lilly made up 0.75% of Meeder Advisory Services's portfolio in Q1 2026, its #24 holding.
  • Meeder Advisory Services first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Meeder Advisory Services's Eli Lilly position peaked at $20.8M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.